Jaw Crushers Market Size, Share, Growth Analysis, By Product(Dust collectors, oil mist collectors, HEPA filters, cartridge collectors and filters), By End-user(Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs)), By Region - Industry Forecast 2024-2031

Global Jaw Crushers Market size was valued at USD 1.5 Billion in 2022 and is poised to grow from USD 1.6 Billion in 2023 to USD 15.48 Billion by 2031, at a CAGR of 11.8% during the forecast period (2024-2031).

The global jaw crusher market is an important segment of the transport industry, because it provides lifestyle-saving treatments for people dwelling with HIV/AIDS. The marketplace has witnessed a sizable boom over the years due to improvements in the scientific era and elevated focus on HIV prevention and treatment.

Factors contributing to marketplace growth include a growing incidence of HIV/AIDS, increasing entry to healthcare services, and ongoing research and improvement sports. The marketplace is primarily pushed with the aid of the demand for antiretroviral remedy (ART), which is the same old treatment for HIV/AIDS. ART enables in reducing the viral load in patients, enhancing immune function, and stopping the transmission of the virus. In 2022 and 2023, the HIV drugs marketplace is expected to maintain its increased trajectory. The marketplace is probable to be prompted by way of several elements, inclusive of:

Increasing HIV/AIDS Prevalence: The number of people dwelling with HIV/AIDS is predicted to grow, mainly in growing nations. This will power the demand for HIV drugs.

Ongoing research and improvement activities are predicted to cause the introduction of recent and more powerful HIV tablets. Technological advancements, which include long-acting injectable treatments, also are expected to form the market. The COVID-19 pandemic has had some effect on the HIV tablets market, with disruptions in delivery chains and healthcare structures. However, efforts are being made to ensure continuity in HIV treatment and prevention services.